Che, Jingmin
Chen, Bo
Wang, Xusheng
Liu, Baoe
Xu, Cuixiang
Wang, Huxia
Sun, Jingying
Feng, Qing
Zhao, Xiangrong
Song, Zhangjun
Funding for this research was provided by:
Open Funds for Shaanxi Provincial Key Laboratory of Infection and Immune Diseases (2022-KFZD-2)
Natural Science Basic Research Program of Shaanxi Province (2022JZ-57)
Technology Talent Support Program of Shaanxi Provincial People’s Hospital (2021LJ-01)
Shaanxi Qinchuangyuan traditional Chinese medicine innovation research and development program (2022-QCYZH-004)
Article History
Received: 19 September 2024
Accepted: 2 January 2025
First Online: 8 January 2025
Declarations
:
: In accordance with the Declaration of Helsinki, this study was approved by the Ethics Committee of Shaanxi Cancer Hospital, ethical approval number: Yilunshen (2024 Ke) No. 11.
: Not Applicable.
: The authors declare no competing interests.